IHMA supports all phases of anti-infective therapy development, from discovery through commercialization. We are your essential resource for central, reference, and clinical research laboratory services worldwide.
IHMA supports companies needing:
- Pre-clinical studies for regulatory filings
- Global laboratory services for all phases of clinical trials
- Antimicrobial resistance (AMR) surveillance (bacterial and fungal)
- Molecular characterization and detection of infectious agents
- New therapeutic approaches (bacteriophage, vaccine, etc.)
- In vitro diagnostic device studies
We utilize a collaborative
and flexible approach to
Supported by our comprehensive microbiology expertise, IHMA employs a collaborative and flexible approach leading to premier testing and results as well as sound economic frameworks. We can also customize our services to best align with per protocol specifications and unique testing needs.